Parametrica Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,956
Closed -$348K 123
2022
Q2
$348K Buy
+1,956
New +$349K 0.38% 69
2021
Q2
Sell
-1,523
Closed -$251K 142
2021
Q1
$251K Sell
1,523
-2,320
-60% -$375K 0.12% 127
2020
Q4
$604K Sell
3,843
-4,945
-56% -$730K 0.37% 58
2020
Q3
$1.31M Sell
8,788
-2,138
-20% -$316K 2.47% 11
2020
Q2
$1.53M Buy
10,926
+528
+5% +$76.9K 1.68% 15
2020
Q1
$1.36M Buy
+10,398
New +$1.48M 1.38% 16
2019
Q1
Sell
-2,494
Closed -$322K 246
2018
Q4
$322K Sell
2,494
-708
-22% -$98.8K 0.39% 96
2018
Q3
$442K Buy
+3,202
New +$426K 0.97% 14
2018
Q1
Sell
-4,386
Closed -$613K 321
2017
Q4
$613K Buy
4,386
+286
+7% +$39.8K 0.39% 37
2017
Q3
$533K Buy
4,100
+1,503
+58% +$199K 0.22% 69
2017
Q2
$344K Buy
2,597
+465
+22% +$59.3K 0.32% 101
2017
Q1
$266K Buy
+2,132
New +$255K 0.28% 185

Other funds holding JNJ

Parametrica Management's JNJ Position: Q3 2022 in Review

Parametrica Management sold out of Johnson & Johnson (JNJ) in Q3 2022, closing a stake of 1,956 shares — an estimated $348K sold.

Parametrica Management first reported a position in JNJ in Q1 2017 and held it in 12 quarters. The position peaked at $1.53M in Q2 2020. 3,622 funds tracked by Wall St. Rank hold JNJ as of Q3 2022.

  • Parametrica Management reported no remaining Johnson & Johnson position as of Q3 2022 after selling out during the quarter.
  • Parametrica Management sold 1,956 Johnson & Johnson shares in Q3 2022, an estimated $348K.
  • Parametrica Management first reported a position in Johnson & Johnson in Q1 2017 and held it in 12 quarters.
  • Parametrica Management's Johnson & Johnson position peaked at $1.53M in Q2 2020.
  • 3,622 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2022.

Based on Parametrica Management's 13F filing for Q3 2022, filed 3 Nov 2022.